Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 2, 2019JAMAOpen Access

Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock

View Full Paper
Ask AI
Bookmark
Share

Authors

PLPierre‐François LaterreNorthwestern UniversitySBScott BerryBerry & Associates (United States)ABAllan BlemingsLeo Pharma (Denmark)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Laterre et al. (2019) studied this question.

synapsesocial.com/papers/6a8c44da3f4b845513e8d43ehttps://doi.org/10.1001/jama.2019.14607
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)2016 · 29,137 citations
  2. 2The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis*2014 · 71 citations
  3. 3Hydrocortisone plus Fludrocortisone for Adults with Septic Shock2018 · 947 citations
  4. 4Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP2000 · 272 citations
  5. 5Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)2011 · 10,335 citations